20-518 Phase I
A Phase I Clinical Trial with TriPRIL CAR T Cells for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
A Phase I Clinical Trial with TriPRIL CAR T Cells for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
A phase II study of ISABELA: isatuximab, belantamab mafodotin, pomalidomide, and dexamethasone in relapsed and refractory multiple myeloma
Clinical-grade Molecular Profiling of Patients with Multiple Myeloma and Related Plasma Cell Malignancies
Phase II study on Acalabrutinib and anti-CD20 antibody in Patients with Anti-MAG Mediated Neuropathy